newsfilter
← Latest News
PR Newswire·

Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial...